Jennifer Nielsen Kahn

Title: Jennifer Nielsen Kahn: Innovator in Fungal Drug Resistance Detection

Introduction

Jennifer Nielsen Kahn is a prominent inventor based in East Brunswick, NJ (US). She has made significant contributions to the field of medical diagnostics, particularly in the detection of fungal drug resistance. With a total of 5 patents, her work has been instrumental in advancing the understanding and treatment of fungal infections.

Latest Patents

Among her latest patents, Kahn has developed assays for resistance to echinocandin-class drugs. These nucleic acid amplification assays target mutations in two short sections of the fungal gene FKS1. Mutations in these sequences have been shown to correlate with resistance to echinocandin-class drugs. The assays may include detection by sequencing or by labeled hybridization probes. Additionally, she has created primers, probes, and reagent kits for performing such assays, further enhancing the capabilities of diagnostic testing in this area.

Career Highlights

Throughout her career, Kahn has worked with notable organizations such as Merck & Company, Inc. and Rutgers, the State University of New Jersey. Her experience in these institutions has allowed her to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Some of her coworkers include Cameron M Douglas and Rosemarie Kelly. Their collaborative efforts have played a vital role in the development of innovative solutions for detecting drug resistance in fungal infections.

Conclusion

Jennifer Nielsen Kahn's contributions to the field of medical diagnostics, particularly in the detection of fungal drug resistance, highlight her innovative spirit and dedication to improving healthcare. Her patents and collaborations continue to influence the landscape of medical research and diagnostics.